FESM, TSMZ: Big ETF Outflows
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 14 2025
0mins
Source: NASDAQ.COM
ETF Outflow Details: The Direxion Daily TSM Bear 1X Shares experienced the largest outflow, losing 75,000 units, which is a 37.5% decrease in outstanding units compared to the previous week.
Author's Perspective: The opinions expressed in the article reflect the author's views and do not necessarily align with those of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OPCH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OPCH
Wall Street analysts forecast OPCH stock price to rise
10 Analyst Rating
9 Buy
1 Hold
0 Sell
Strong Buy
Current: 22.230
Low
27.00
Averages
36.22
High
40.00
Current: 22.230
Low
27.00
Averages
36.22
High
40.00
About OPCH
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Option Care Health Under Investigation for Securities Violations
- Declining Financial Performance: In Q1 2026, Option Care Health reported revenue of $1.35 billion, a mere 1.3% year-over-year increase, falling short of market expectations, indicating significant competitive pressure on the company.
- Profitability Erosion: The company posted a net income of $45.3 million, down 3.0% year-over-year, with adjusted EBITDA at $104.8 million, a 6.3% decline, reflecting ongoing deterioration in profitability that could undermine investor confidence.
- Guidance Reduction: Citing lower CID patient retention and therapy mix, the company revised its full-year 2026 revenue guidance down from $5.8B-$6.0B to $5.675B-$5.775B, highlighting uncertainty in future growth prospects.
- Stock Price Volatility: Following the guidance cut, Option Care Health's stock plummeted from $26.87 on April 29 to $20.33 on April 30, a drop of approximately 24%, signaling a pessimistic market sentiment regarding the company's outlook.
See More
Option Care Health Under Investigation for Securities Violations
- Guidance Downgrade: Option Care Health lowered its full-year revenue guidance from $5.8B-$6.0B to $5.675B-$5.775B in its Q1 2026 report, primarily due to 'lower CID patient retention and therapy mix,' which directly impacts revenue expectations and market confidence.
- Declining Profitability: The company reported Q1 revenue of $1.35B, a mere 1.3% year-over-year increase, with net income at $45.3M, down 3%, and adjusted EBITDA at $104.8M, down 6.3%, indicating ongoing pressure on profitability that could affect investor sentiment.
- Significant Stock Drop: Following the disappointing earnings report, Option Care Health's stock plummeted from $26.87 on April 29 to $20.33 on April 30, a decline of approximately 24%, reflecting market concerns over the company's future performance and prompting investors to reassess their holdings.
- Legal Investigation Initiated: Kirby McInerney LLP is investigating potential violations of federal securities laws by Option Care Health and its executives; while no lawsuit has been filed yet, this inquiry could have significant implications for the company's future legal liabilities and reputation.
See More
Option Care Health Director Increases Shareholding
- Share Purchase Details: On May 7, 2026, Timothy P. Sullivan, Director of Option Care Health, purchased 24,154 shares at a weighted average price of $20.69, totaling approximately $500,000, which increased his direct holdings to 73,383 shares valued at about $1.52 million, indicating his confidence in the company's future prospects.
- Ownership Change: This transaction increased Sullivan's direct ownership by 49.06%, reflecting a strategic decision to rebuild his investment after a significant sale in August 2024, suggesting a reassessment of the company's value.
- Market Context: With Option Care Health's shares declining by 37.9% over the past year, Sullivan's acquisition at a lower price point indicates he perceives the current stock price as undervalued, potentially offering an attractive buying opportunity for investors.
- Investor Signal Interpretation: Sullivan's purchase was discretionary and not part of a pre-scheduled plan, which is often viewed as a positive signal regarding the company's future performance, although the company still needs to address slowing revenue growth to restore market confidence.
See More
Van Berkom Acquires Stake in Option Care Health
- New Investment Position: Van Berkom & Associates Inc. disclosed a new position in Option Care Health on May 7, 2026, acquiring 1,587,636 shares valued at approximately $51.54 million, indicating a long-term confidence in the company despite recent challenges.
- Ownership Proportion: This acquisition represents 1.41% of the fund's reportable assets under management as of March 31, 2026, highlighting Van Berkom's commitment to Option Care amidst performance pressures faced by the company.
- Market Performance Volatility: As of May 6, 2026, Option Care Health's shares closed at $20.45, down 37.5% year-over-year, and plummeted 24% following the first-quarter earnings report, reflecting market concerns regarding its growth outlook.
- Financial Overview: Despite a modest 1.3% year-over-year revenue increase to $1.35 billion in Q1 and a 6.3% decline in adjusted EBITDA to $104.8 million, the company expanded its credit facility and repurchased $17.5 million in stock, demonstrating resilience in challenging conditions.
See More
Option Care Health Under Investigation for Securities Compliance
- Disappointing Earnings Report: On April 30, 2026, Option Care Health reported first-quarter results that fell short of analysts' expectations, resulting in a stock price drop that reflects market concerns about the company's future performance.
- Lowered Full-Year Outlook: The company revised its full-year revenue outlook downward, a decision that could further undermine investor confidence and raise doubts about the company's future profitability among shareholders.
- Legal Investigation Initiated: Holzer & Holzer, LLC is investigating whether Option Care Health complied with federal securities laws, indicating potential legal risks for the company and increasing the likelihood of investor losses.
- Investor Rights Advocacy: Holzer & Holzer is urging affected investors to contact attorneys for legal support, which may trigger a broader trust crisis among shareholders regarding the company's management.
See More
Option Care Health Under Investigation for Securities Violations
- Investigation Launched: The Schall Law Firm has announced an investigation into Option Care Health, Inc. to determine if the company issued false or misleading statements or failed to disclose important information to investors, which could impact the company's reputation and shareholder confidence.
- Financial Performance Decline: Option Care's Q1 financial results released on April 30, 2026, revealed a 3.75% downward revision of its FY 2026 guidance, indicating poor performance in patient retention and therapy mix, which may raise investor concerns about future earnings.
- Stock Price Volatility: Following this news, Option Care's shares opened down 26.4% on the same day, reflecting market pessimism regarding the company's outlook and potentially triggering further legal actions from investors.
- Investor Rights Protection: The Schall Law Firm encourages affected shareholders to participate in the investigation and offers free legal consultations, demonstrating a commitment to protecting investor rights and potentially attracting more shareholders to engage in legal actions.
See More
Option Care Health Under Investigation for Securities Violations
- Declining Financial Performance: In Q1 2026, Option Care Health reported revenue of $1.35 billion, a mere 1.3% year-over-year increase, falling short of market expectations, indicating significant competitive pressure on the company.
- Profitability Erosion: The company posted a net income of $45.3 million, down 3.0% year-over-year, with adjusted EBITDA at $104.8 million, a 6.3% decline, reflecting ongoing deterioration in profitability that could undermine investor confidence.
- Guidance Reduction: Citing lower CID patient retention and therapy mix, the company revised its full-year 2026 revenue guidance down from $5.8B-$6.0B to $5.675B-$5.775B, highlighting uncertainty in future growth prospects.
- Stock Price Volatility: Following the guidance cut, Option Care Health's stock plummeted from $26.87 on April 29 to $20.33 on April 30, a drop of approximately 24%, signaling a pessimistic market sentiment regarding the company's outlook.
See More
Option Care Health Under Investigation for Securities Violations
- Guidance Downgrade: Option Care Health lowered its full-year revenue guidance from $5.8B-$6.0B to $5.675B-$5.775B in its Q1 2026 report, primarily due to 'lower CID patient retention and therapy mix,' which directly impacts revenue expectations and market confidence.
- Declining Profitability: The company reported Q1 revenue of $1.35B, a mere 1.3% year-over-year increase, with net income at $45.3M, down 3%, and adjusted EBITDA at $104.8M, down 6.3%, indicating ongoing pressure on profitability that could affect investor sentiment.
- Significant Stock Drop: Following the disappointing earnings report, Option Care Health's stock plummeted from $26.87 on April 29 to $20.33 on April 30, a decline of approximately 24%, reflecting market concerns over the company's future performance and prompting investors to reassess their holdings.
- Legal Investigation Initiated: Kirby McInerney LLP is investigating potential violations of federal securities laws by Option Care Health and its executives; while no lawsuit has been filed yet, this inquiry could have significant implications for the company's future legal liabilities and reputation.
See More
Option Care Health Director Increases Shareholding
- Share Purchase Details: On May 7, 2026, Timothy P. Sullivan, Director of Option Care Health, purchased 24,154 shares at a weighted average price of $20.69, totaling approximately $500,000, which increased his direct holdings to 73,383 shares valued at about $1.52 million, indicating his confidence in the company's future prospects.
- Ownership Change: This transaction increased Sullivan's direct ownership by 49.06%, reflecting a strategic decision to rebuild his investment after a significant sale in August 2024, suggesting a reassessment of the company's value.
- Market Context: With Option Care Health's shares declining by 37.9% over the past year, Sullivan's acquisition at a lower price point indicates he perceives the current stock price as undervalued, potentially offering an attractive buying opportunity for investors.
- Investor Signal Interpretation: Sullivan's purchase was discretionary and not part of a pre-scheduled plan, which is often viewed as a positive signal regarding the company's future performance, although the company still needs to address slowing revenue growth to restore market confidence.
See More
Van Berkom Acquires Stake in Option Care Health
- New Investment Position: Van Berkom & Associates Inc. disclosed a new position in Option Care Health on May 7, 2026, acquiring 1,587,636 shares valued at approximately $51.54 million, indicating a long-term confidence in the company despite recent challenges.
- Ownership Proportion: This acquisition represents 1.41% of the fund's reportable assets under management as of March 31, 2026, highlighting Van Berkom's commitment to Option Care amidst performance pressures faced by the company.
- Market Performance Volatility: As of May 6, 2026, Option Care Health's shares closed at $20.45, down 37.5% year-over-year, and plummeted 24% following the first-quarter earnings report, reflecting market concerns regarding its growth outlook.
- Financial Overview: Despite a modest 1.3% year-over-year revenue increase to $1.35 billion in Q1 and a 6.3% decline in adjusted EBITDA to $104.8 million, the company expanded its credit facility and repurchased $17.5 million in stock, demonstrating resilience in challenging conditions.
See More
Option Care Health Under Investigation for Securities Compliance
- Disappointing Earnings Report: On April 30, 2026, Option Care Health reported first-quarter results that fell short of analysts' expectations, resulting in a stock price drop that reflects market concerns about the company's future performance.
- Lowered Full-Year Outlook: The company revised its full-year revenue outlook downward, a decision that could further undermine investor confidence and raise doubts about the company's future profitability among shareholders.
- Legal Investigation Initiated: Holzer & Holzer, LLC is investigating whether Option Care Health complied with federal securities laws, indicating potential legal risks for the company and increasing the likelihood of investor losses.
- Investor Rights Advocacy: Holzer & Holzer is urging affected investors to contact attorneys for legal support, which may trigger a broader trust crisis among shareholders regarding the company's management.
See More
Option Care Health Under Investigation for Securities Violations
- Investigation Launched: The Schall Law Firm has announced an investigation into Option Care Health, Inc. to determine if the company issued false or misleading statements or failed to disclose important information to investors, which could impact the company's reputation and shareholder confidence.
- Financial Performance Decline: Option Care's Q1 financial results released on April 30, 2026, revealed a 3.75% downward revision of its FY 2026 guidance, indicating poor performance in patient retention and therapy mix, which may raise investor concerns about future earnings.
- Stock Price Volatility: Following this news, Option Care's shares opened down 26.4% on the same day, reflecting market pessimism regarding the company's outlook and potentially triggering further legal actions from investors.
- Investor Rights Protection: The Schall Law Firm encourages affected shareholders to participate in the investigation and offers free legal consultations, demonstrating a commitment to protecting investor rights and potentially attracting more shareholders to engage in legal actions.
See More
